×

CNBC Utilities Page Drugs

  • Shedding light on Alzheimer’s

    What goes wrong in the brain in Alzheimer’s disease is one of the great mysteries of medicine. New research out of MIT may shed light on the problem. CNBC's Meg Tirrell reports the latest.

  • A patient gets a checkup from infectious disease doctor Fadi Al Akhrass, at the Pikeville Medical Center in Pikeville, KY.

    A rural and urban divide, along with racial differences, were also evident in a new report on drug overdoses, USA Today reports.

  • The Missouri senator's investigation comes amid an epidemic of opioid addiction, with 91 Americans dying everyday as a result of overdose, according to the U.S. Centers for Disease Control and Prevention. "This epidemic is the direct result of a calculated sales and marketing strategy major opioid manufacturers have allegedly pursued over the past 20 years...

  • Regeneron's new drug

    CNBC's Meg Tirrell reports the latest on Regeneron Pharmaceuticals getting FDA approval for potentially an important drug.

  • The Missouri senator's investigation comes amid an epidemic of opioid addiction, with 91 Americans dying everyday as a result of overdose, according to the U.S. Centers for Disease Control and Prevention. "This epidemic is the direct result of a calculated sales and marketing strategy major opioid manufacturers have allegedly pursued over the past 20 years...

  • The Missouri senator's investigation comes amid an epidemic of opioid addiction, with 91 Americans dying everyday as a result of overdose, according to the U.S. Centers for Disease Control and Prevention. "This epidemic is the direct result of a calculated sales and marketing strategy major opioid manufacturers have allegedly pursued over the past 20 years...

  • WASHINGTON— A Democratic senator is seeking marketing information, sales records and studies from manufacturers of the top-selling opioid products in the United States to determine whether drugmakers have contributed to an overuse of the pain killers. Claire McCaskill of Missouri said that sales of prescription opioids have quadrupled since 1999,...

  • LONDON, March 27- International groups representing doctors and patients have launched a fresh challenge to the patent on Gilead Sciences' hepatitis C drug sofosbuvir at the European Patent Office in order to increase access to the treatment. If the latest patent challenge is successful, it could make cheaper generic versions of sofosbuvir available in...

  • A man smokes a cigarette of marijuana in an Amsterdam cafe

    Canadians will be free to smoke and grow their own cannabis from next July under new laws which legalize the possession of marijuana.

  • An Afghan poppy farmer uses a blade to score the surface of a poppy in order to extract raw opium in Laghman province, Afghanistan.

    Afghanistan's opium production is up because of new genetically modified "Chinese seed" that allows opium to be grown year round.

  • WASHINGTON— With time running out to get votes for the Republican plan to repeal and replace "Obamacare," President Donald Trump has shown he's willing to make a deal. Looking to win support, the White House offered to make the change, but the proposal irked some more moderate members and the future of the provisions remained fluid late Thursday night.

  • Mylan EpiPen

    Mylan has recalled about 81,000 EpiPen devices outside the United States, following two reports of product failure.

  • The government has turned to relatively unknown institutions to provide a service known as correspondent banking, as international banks are increasingly concerned about the risks of doing business with socialist-ruled Venezuela amid investigations into corruption and drug trafficking. It also coincides with complaints by President Nicolas Maduro...

  • *Co to discuss next steps with FDA, looks for strategic partner. The company's stock jumped about 19 percent to $19.50 in premarket trading on Monday. Everyday, 91 Americans die of opioid overdose, the U.S. Centers for Disease Control and Prevention estimates.

  • March 20- Nektar Therapeutics said its experimental opioid, designed to achieve pain relief without the high levels of euphoria that can lead to abuse and addiction with existing opioids, succeeded in a key late-stage study. U.S. regulators and lawmakers have taken a number of steps to control the supply of opioids as the country is engulfed in an epidemic of...

  • Connecticut and Alaska are two of the latest considering legislation this year that would create a "non-opioid directive" patients can put in their medical files, formally notifying health care professionals they do not want to be prescribed or administered opioid medications. Legislators in Massachusetts and Pennsylvania last year voted to create...

  • Bad news about new cholesterol drugs

    There's a major advancement in fighting heart disease, but the new drug behind it is not cheap. CNBC's Meg Tirrell reports the latest on this cholesterol drug from Amgen.

  • March 14- The benefits of Endo International Plc's long-acting opioid painkiller no longer outweigh its risks, an independent panel to the U.S. Food and Drug Administration concluded on Tuesday. However, data shows that while nasal abuse has reduced with the reformulation, rates of intravenous abuse increased, FDA staff noted in their review on Thursday,...

  • March 14- The benefits of Endo International Plc's long-acting opioid painkiller no longer outweigh its risks, an independent panel to the U.S. Food and Drug Administration concluded on Tuesday. The Centers for Disease Control and Prevention estimates at least 91 Americans succumb every day to opioid overdose. Data shows that while nasal abuse has reduced...

  • March 14- The benefits of Endo International Plc's long-acting opioid painkiller no longer outweigh its risks, an independent panel to the U.S. Food and Drug Administration concluded on Tuesday. The drug, Opana ER, is a long-acting variation of oxymorphine that is intended to treat pain severe enough to require daily, around-the-clock, long-term opioid...